Cargando…
Mitochondrial Phenotypes in Parkinson’s Diseases—A Focus on Human iPSC-Derived Dopaminergic Neurons
Established disease models have helped unravel the mechanistic underpinnings of pathological phenotypes in Parkinson’s disease (PD), the second most common neurodegenerative disorder. However, these discoveries have been limited to relatively simple cellular systems and animal models, which typicall...
Autores principales: | Heger, Leonie M., Wise, Rachel M., Hees, J. Tabitha, Harbauer, Angelika B., Burbulla, Lena F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699816/ https://www.ncbi.nlm.nih.gov/pubmed/34943944 http://dx.doi.org/10.3390/cells10123436 |
Ejemplares similares
-
Identification of ASCL1 as a determinant for human iPSC-derived dopaminergic neurons
por: Earley, Aaron M., et al.
Publicado: (2021) -
Metabolic Regulation of Mitochondrial Protein Biogenesis from a Neuronal Perspective
por: Hees, Jara Tabitha, et al.
Publicado: (2022) -
The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
por: Minakaki, Georgia, et al.
Publicado: (2020) -
Aberrant epigenome in iPSC‐derived dopaminergic neurons from Parkinson's disease patients
por: Fernández‐Santiago, Rubén, et al.
Publicado: (2015) -
Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson’s disease patients
por: Fernández-Santiago, Rubén, et al.
Publicado: (2019)